|
Clinical Trials and Observations
Citations 311-320 of 2742 total displayed.
|
Past content
(since May 1998):
|
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
- Syed Khizer Hasan, Ashley N. Mays, Tiziana Ottone, Antonio Ledda, Giorgio La Nasa, Chiara Cattaneo, Erika Borlenghi, Lorella Melillo, Enrico Montefusco, José Cervera, Christopher Stephen, Gnanam Satchi, Anne Lennard, Marta Libura, Jo Ann W. Byl, Neil Osheroff, Sergio Amadori, Carolyn A. Felix, Maria Teresa Voso, Wolfgang R. Sperr, Jordi Esteve, Miguel A. Sanz, David Grimwade, and Francesco Lo-Coco
Blood 2008; 112: 3383-3390.
[Abstract]
[Full text]
[PDF]
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
- Daniel T. Starczynowski, Suzanne Vercauteren, Adele Telenius, Sandy Sung, Kaoru Tohyama, Angela Brooks-Wilson, John J. Spinelli, Connie J. Eaves, Allen C. Eaves, Douglas E. Horsman, Wan L. Lam, and Aly Karsan
Blood 2008; 112: 3412-3424.
[Abstract]
[Full text]
[PDF]
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia
- Stephanie J. Lee, Manisha Kukreja, Tao Wang, Sergio A. Giralt, Jeffrey Szer, Mukta Arora, Ann E. Woolfrey, Francisco Cervantes, Richard E. Champlin, Robert Peter Gale, Joerg Halter, Armand Keating, David I. Marks, Philip L. McCarthy, Eduardo Olavarria, Edward A. Stadtmauer, Manuel Abecasis, Vikas Gupta, H. Jean Khoury, Biju George, Gregory A. Hale, Jane L. Liesveld, David A. Rizzieri, Joseph H. Antin, Brian J. Bolwell, Matthew H. Carabasi, Edward Copelan, Osman Ilhan, Mark R. Litzow, Harold C. Schouten, Axel R. Zander, Mary M. Horowitz, and Richard T. Maziarz
Blood 2008; 112: 3500-3507.
[Abstract]
[Full text]
[PDF]
The hazards of blood transfusion in historical perspective
- Harvey J. Alter and Harvey G. Klein
Blood 2008; 112: 2617-2626.
[Abstract]
[Full text]
[PDF]
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
- Mary E. D. Flowers, Jane F. Apperley, Koen van Besien, Ahmet Elmaagacli, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luis Bouzas, Mauricette Michallet, H. Miles Prince, Robert Knobler, Dennis Parenti, Jose Gallo, and Hildegard T. Greinix
Blood 2008; 112: 2667-2674.
[Abstract]
[Full text]
[PDF]
High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE)
- Alanna M. Chamberlain, Aaron R. Folsom, Susan R. Heckbert, Wayne D. Rosamond, and Mary Cushman
Blood 2008; 112: 2675-2680.
[Abstract]
[Full text]
[PDF]
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome
- Bart L. Scott, Denise A. Wells, Michael R. Loken, David Myerson, Wendy M. Leisenring, and H. Joachim Deeg
Blood 2008; 112: 2681-2686.
[Abstract]
[Full text]
[PDF]
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
- Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels S. Andersen, Lone B. Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, and for the Nordic Lymphoma Group
Blood 2008; 112: 2687-2693.
[Abstract]
[Full text]
[PDF]
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
- Thomas M. Habermann, Sophia S. Wang, Matthew J. Maurer, Lindsay M. Morton, Charles F. Lynch, Stephen M. Ansell, Patricia Hartge, Richard K. Severson, Nathaniel Rothman, Scott Davis, Susan M. Geyer, Wendy Cozen, Stephen J. Chanock, and James R. Cerhan
Blood 2008; 112: 2694-2702.
[Abstract]
[Full text]
[PDF]
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
- Cihan Ay, Ralph Simanek, Rainer Vormittag, Daniela Dunkler, Guelay Alguel, Silvia Koder, Gabriela Kornek, Christine Marosi, Oswald Wagner, Christoph Zielinski, and Ingrid Pabinger
Blood 2008; 112: 2703-2708.
[Abstract]
[Full text]
[PDF]
|
|
